João Lauro Viana de Camargo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
João Lauro Viana de Camargo has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Luís Fernando Barbisan
Department of Structural and Functional Biology, Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil
16 shared publications Maria Aparecida Marchesan Rodrigues
Medical School, UNESP–São Paulo State University, Department of Pathology, Botucatu-SP, Brazil
8 shared publicationsCarla Adriene da Silva Franchi
Center for the Evaluation of the Environmental Impact on Human Health (TOXICAM), Department of Pathology, Botucatu Medical School, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil
5 shared publications- Daisy Maria Fávero Salvadori
Universidade Estadual Paulista, Brazil
5 shared publications Ana Lúcia Tozzi Spinardi-Barbisan
UNESP São Paulo State University, School of Medicine, Department of Pathology, Botucatu, 18618-000, SP, Brazil
4 shared publicationsLúcia Regina Ribeiro
Núcleo de Avaliação Toxicogenética e Cancerígena – TOXICAN, Faculdade de Medicina – UNESP, Departamento de Patologia, Botucatu – SP – Brazil
4 shared publications
Latest Publications
- 19 September 2024
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 47 (6) , 1382-1392
Uncoupling as initiating event in mitochondrial dysfunction after diuron exposure
Diuron, a herbicide derived from urea, has been shown to induce urinary bladder urothelial tumors in rodents, leading the U.S. Environmental Protection Agency (USEPA) to designate it as a 'known/likely' human carcinogen. In our laboratory, a series of studies investigating the carcinogenic mode of action (MoA) of Diuron have consistently revealed its cytotoxic effects on the urinary bladder urothelium. Prolonged exposure to relatively high doses of Diuron results in urothelial necrosis, regenerative hyperplasia, and eventually, the development of tumors. The hypothesis posited is that Diuron and its metabolites exert toxicity by causing damage to mitochondria, a phenomenon referred to as mitotoxicity. Our research focuses on evaluating how Diuron and its metabolites affect mitochondria isolated from both the urothelium and the liver, the primary organ for Diuron biotransformation. In this context, we present and discuss data pertaining to mitochondria isolated from the liver of Wistar rats exposed to Diuron or its metabolites 3-(3,4-diclorofenil)-1-metilureia (DCPMU) or 3,4-dichloroaniline (DCA) at concentrations ranging from 0.5 to 500 µM in vitro. The findings indicate that, at concentrations of 100 and 500 µM, the tested chemicals induce uncoupling of oxidative phosphorylation, as evidenced by the dissipation of mitochondrial membrane potential and basal oxygen consumption. Notably, at 500 µM, DCA causes mitochondrial swelling, a morphofunctional indicator of severe organelle damage. These outcomes underscore the classification of Diuron and its metabolites, DCA and DCPMU, as mitotoxic to liver cells, given the pronounced mitochondrial dysfunction they induce.
- 19 September 2024
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 47 (6) , 1382-1392
Uncoupling as initiating event in mitochondrial dysfunction after diuron exposure
Diuron, a herbicide derived from urea, has been shown to induce urinary bladder urothelial tumors in rodents, leading the U.S. Environmental Protection Agency (USEPA) to designate it as a 'known/likely' human carcinogen. In our laboratory, a series of studies investigating the carcinogenic mode of action (MoA) of Diuron have consistently revealed its cytotoxic effects on the urinary bladder urothelium. Prolonged exposure to relatively high doses of Diuron results in urothelial necrosis, regenerative hyperplasia, and eventually, the development of tumors. The hypothesis posited is that Diuron and its metabolites exert toxicity by causing damage to mitochondria, a phenomenon referred to as mitotoxicity. Our research focuses on evaluating how Diuron and its metabolites affect mitochondria isolated from both the urothelium and the liver, the primary organ for Diuron biotransformation. In this context, we present and discuss data pertaining to mitochondria isolated from the liver of Wistar rats exposed to Diuron or its metabolites 3-(3,4-diclorofenil)-1-metilureia (DCPMU) or 3,4-dichloroaniline (DCA) at concentrations ranging from 0.5 to 500 µM in vitro. The findings indicate that, at concentrations of 100 and 500 µM, the tested chemicals induce uncoupling of oxidative phosphorylation, as evidenced by the dissipation of mitochondrial membrane potential and basal oxygen consumption. Notably, at 500 µM, DCA causes mitochondrial swelling, a morphofunctional indicator of severe organelle damage. These outcomes underscore the classification of Diuron and its metabolites, DCA and DCPMU, as mitotoxic to liver cells, given the pronounced mitochondrial dysfunction they induce.
- 18 April 2022
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 32 (8) , 628-635
Molecular signatures associated with diuron exposure on rat urothelial mitochondria
Diuron, 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a worldwide used herbicide whose biotransformation gives rise to the metabolites, 3-(3,4-dichlorophenyl)-1-methylurea (DCPMU) and 3,4-dichloroaniline (DCA). Previous studies indicate that diuron and/or its metabolites are toxic to the bladder urothelium of the Wistar rats where, under certain conditions of exposure, they may induce successively urothelial cell degeneration, necrosis, hyperplasia and eventually tumors. The hypothesis was raised that the molecular initiating event (MIE) of this Adverse Outcome Pathway is the mitochondrial toxicity of those compounds. Therefore, this study aimed to investigate in vitro the metabolic alterations resulting from urothelial mitochondria isolated from male Wistar rats exposure to diuron, DCPMU and DCA at 10 and 100 µM. A non-targeted metabolomic analysis using mass spectrometry showed discriminative clustering among groups and alterations in the intensity abundance of membrane-associated molecules phosphatidylcholine, phosphatidylinositol and phosphatidylserine, in addition to methylhexanoyl-CoA and, particularly for diuron 100 µM, dehydro-L-gulonate, all of them involved in critical mitochondrial metabolism. Collectively, these data indicate the mitochondrial dysfunction as an MIE that triggers cellular damage and death observed in previous studies.
- 18 April 2022
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 32 (8) , 628-635
Molecular signatures associated with diuron exposure on rat urothelial mitochondria
Diuron, 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a worldwide used herbicide whose biotransformation gives rise to the metabolites, 3-(3,4-dichlorophenyl)-1-methylurea (DCPMU) and 3,4-dichloroaniline (DCA). Previous studies indicate that diuron and/or its metabolites are toxic to the bladder urothelium of the Wistar rats where, under certain conditions of exposure, they may induce successively urothelial cell degeneration, necrosis, hyperplasia and eventually tumors. The hypothesis was raised that the molecular initiating event (MIE) of this Adverse Outcome Pathway is the mitochondrial toxicity of those compounds. Therefore, this study aimed to investigate in vitro the metabolic alterations resulting from urothelial mitochondria isolated from male Wistar rats exposure to diuron, DCPMU and DCA at 10 and 100 µM. A non-targeted metabolomic analysis using mass spectrometry showed discriminative clustering among groups and alterations in the intensity abundance of membrane-associated molecules phosphatidylcholine, phosphatidylinositol and phosphatidylserine, in addition to methylhexanoyl-CoA and, particularly for diuron 100 µM, dehydro-L-gulonate, all of them involved in critical mitochondrial metabolism. Collectively, these data indicate the mitochondrial dysfunction as an MIE that triggers cellular damage and death observed in previous studies.
- Open Access
- 31 August 2021
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- Vol. 9 (3) , 2-13
Adverse outcome pathways – development and potential regulatory application
Introduction: Over the last two decades, chemical safety assessment and regulatory toxicology have progressed from empirical science based on direct observation of apical adverse outcomes in whole organisms to a predictive practice that infers outcomes and risks on the basis of accumulated understanding of toxicological mechanisms and modes of action. Objective: To provide general concepts on how Adverse Outcome Pathways (AOPs) are developed and examples related to skin sensitization, endocrine, disruption, and mitochondrial dysfunction. Method: Narrative review based on data of the scientific literature relevant to the theme addressed and on the experience of the authors. Results: An AOP framework provides a systematic approach to organize knowledge about mechanisms of toxicity that may inform analytical domains in regulatory decision-making. AOPs are open structures that may indicate not only data gaps in the understanding of a toxicity process, but also testing procedures that will generate the necessary knowledge to fill those gaps. Every AOP should be continuously refined through the collaborative efforts of the scientific community. Depending on the amount and detail of information that is successively inserted, AOP may progress from the stage of a putative AOP to the stages of qualitative and quantitative AOPs, which are more fit-for-purpose to support regulatory decision-making. Conclusions: Continuous collaboration between AOP developers within the scientific community and the regulatory corps toward the development of this mechanistic structure will support the advancement of toxicological sciences, regardless of its immediate application for regulatory purposes.
- 31 August 2021
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- Vol. 9 (3) , 2-13
Open AccessAdverse outcome pathways – development and potential regulatory application
Introduction: Over the last two decades, chemical safety assessment and regulatory toxicology have progressed from empirical science based on direct observation of apical adverse outcomes in whole organisms to a predictive practice that infers outcomes and risks on the basis of accumulated understanding of toxicological mechanisms and modes of action. Objective: To provide general concepts on how Adverse Outcome Pathways (AOPs) are developed and examples related to skin sensitization, endocrine, disruption, and mitochondrial dysfunction. Method: Narrative review based on data of the scientific literature relevant to the theme addressed and on the experience of the authors. Results: An AOP framework provides a systematic approach to organize knowledge about mechanisms of toxicity that may inform analytical domains in regulatory decision-making. AOPs are open structures that may indicate not only data gaps in the understanding of a toxicity process, but also testing procedures that will generate the necessary knowledge to fill those gaps. Every AOP should be continuously refined through the collaborative efforts of the scientific community. Depending on the amount and detail of information that is successively inserted, AOP may progress from the stage of a putative AOP to the stages of qualitative and quantitative AOPs, which are more fit-for-purpose to support regulatory decision-making. Conclusions: Continuous collaboration between AOP developers within the scientific community and the regulatory corps toward the development of this mechanistic structure will support the advancement of toxicological sciences, regardless of its immediate application for regulatory purposes.
- Open Access
- 31 October 2018
- Published by Revinter in Revista Intertox de Toxicologia, Risco Ambiental e Sociedade
- Vol. 11 (3)
Proliferação celular na pelve renal de ratos expostos ao herbicida diuron ou ao adoçante artificial sacarina sódica
O aumento da proliferação celular no urotélio da bexiga de ratos expostos aos cancerígenos químicos diuron ou sacarina sódica (SNa) está associado à citotoxicidade ou à abrasão, respectivamente. Neste estudo foram estudadas as taxas de proliferação celular (Indice de marcação, IM) no urotélio da pelve renal de ratos alimentados com diuron 2500ppm ou SNa 710ppm por 07 dias ou 15 semanas. Aqueles agentes provocaram aumentos do IM e da incidência de hiperplasia urotelial em relação aos controles, embora de modo não significativo. Os resultados indicam que o urotélio da pelve renal é também suscetível a agentes químicos que aumentam a proliferação celular por diferentes modos de ação na bexiga urinária.
- 31 October 2018
- Published by Revinter in Revista Intertox de Toxicologia, Risco Ambiental e Sociedade
- Vol. 11 (3)
Open AccessProliferação celular na pelve renal de ratos expostos ao herbicida diuron ou ao adoçante artificial sacarina sódica
O aumento da proliferação celular no urotélio da bexiga de ratos expostos aos cancerígenos químicos diuron ou sacarina sódica (SNa) está associado à citotoxicidade ou à abrasão, respectivamente. Neste estudo foram estudadas as taxas de proliferação celular (Indice de marcação, IM) no urotélio da pelve renal de ratos alimentados com diuron 2500ppm ou SNa 710ppm por 07 dias ou 15 semanas. Aqueles agentes provocaram aumentos do IM e da incidência de hiperplasia urotelial em relação aos controles, embora de modo não significativo. Os resultados indicam que o urotélio da pelve renal é também suscetível a agentes químicos que aumentam a proliferação celular por diferentes modos de ação na bexiga urinária.
- 1 December 2016
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 82, A1-A2
Whither the impending european regulation of presumed endocrine disruptors?
- 1 December 2016
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 82, A1-A2
Whither the impending european regulation of presumed endocrine disruptors?
- 1 July 2015
- Published by Elsevier in Toxicology
- Vol. 333, 100-106
Evaluation of early changes induced by diuron in the rat urinary bladder using different processing methods for scanning electron microscopy
- 1 July 2015
- Published by Elsevier in Toxicology
- Vol. 333, 100-106
Evaluation of early changes induced by diuron in the rat urinary bladder using different processing methods for scanning electron microscopy
- 1 November 2014
- Published by Elsevier in Toxicology
- Vol. 325, 21-30
Dose and temporal effects on gene expression profiles of urothelial cells from rats exposed to diuron
- 1 November 2014
- Published by Elsevier in Toxicology
- Vol. 325, 21-30
Dose and temporal effects on gene expression profiles of urothelial cells from rats exposed to diuron
- 1 December 2013
- Published by Elsevier in Toxicology
- Vol. 314 (2-3) , 238-246
Diuron metabolites and urothelial cytotoxicity: In vivo, in vitro and molecular approaches
- 1 December 2013
- Published by Elsevier in Toxicology
- Vol. 314 (2-3) , 238-246
Diuron metabolites and urothelial cytotoxicity: In vivo, in vitro and molecular approaches
- 1 August 2013
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 31 (6) , 827-835
Chromosomal imbalances in successive moments of human bladder urothelial carcinoma
- 1 August 2013
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 31 (6) , 827-835
Chromosomal imbalances in successive moments of human bladder urothelial carcinoma
- Open Access
- 4 April 2013
- Published by Springer Nature in BMC Proceedings
- Vol. 7 (S2) , K10
Chemical carcinogenesis – mode of action to inform quantitative human risk
- 4 April 2013
- Published by Springer Nature in BMC Proceedings
- Vol. 7 (S2) , K10
Open AccessChemical carcinogenesis – mode of action to inform quantitative human risk